0001694665-21-000019.txt : 20210129 0001694665-21-000019.hdr.sgml : 20210129 20210129172829 ACCESSION NUMBER: 0001694665-21-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210127 FILED AS OF DATE: 20210129 DATE AS OF CHANGE: 20210129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zung Jonathan B. CENTRAL INDEX KEY: 0001837972 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38473 FILM NUMBER: 21572974 MAIL ADDRESS: STREET 1: C/O EVELO BIOSCIENCES, INC. STREET 2: 620 MEMORIAL DRIVE, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evelo Biosciences, Inc. CENTRAL INDEX KEY: 0001694665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465594527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 620 MEMORIAL DRIVE STREET 2: SUITE 200 WEST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617 870 8281 MAIL ADDRESS: STREET 1: 620 MEMORIAL DRIVE STREET 2: SUITE 200 WEST CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_161195929825887.xml FORM 4 X0306 4 2021-01-27 0 0001694665 Evelo Biosciences, Inc. EVLO 0001837972 Zung Jonathan B. C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139 0 1 0 0 Chief Development Officer Stock Option (Right to Buy) 16.65 2021-01-27 4 A 0 300000 0 A 2031-01-27 Common Stock 300000.0 300000 D This option will vest as to 25% of the total grant on January 4, 2022 and the remainder vesting thereafter in thirty-six (36) substantially equal monthly installments, subject to continued employment on such dates. /s/ Daniel S. Char, Attorney-in-Fact for Jonathan B. Zung 2021-01-29